Guohao Wei
Overview
Explore the profile of Guohao Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei G, Fan L, Song X, Zhou W, Sun M, Sun Y, et al.
Discov Oncol
. 2025 Feb;
16(1):187.
PMID: 39954036
Background: Almonertinib is a third-generation EGFR-TKI, and studies on its resistance mechanisms are lacking. Cancer-associated fibroblasts (CAFs) can influence resistance to targeted therapeutics, but their role and mechanism of action...
2.
Wei G, Nie Y, Sun M, Zhou W, Zhao H, Chen F, et al.
J Transl Med
. 2025 Jan;
23(1):42.
PMID: 39794783
Background: Almonertinib is the initial third-generation EGFR-TKI in China, but its resistance mechanism is unknown. Cancer-associated fibroblasts (CAFs) are essential matrix components in the tumor microenvironment, but their impact on...
3.
Shan F, Huang J, Tang C, Liu L, Zhu Y, Wei G, et al.
Sci Rep
. 2024 Nov;
14(1):29478.
PMID: 39604490
Metal nanoparticles have attracted great interest because of their unique near-field enhancement properties, and have important applications in many fields, such as surface-enhanced Raman scattering (SERS), fluorescence enhancement, solar cell...
4.
Shan F, Huang J, Zhu Y, Wei G
Molecules
. 2024 Sep;
29(18).
PMID: 39339282
Three-dimensional plasma nanostructures with high light-thermal conversion efficiency show the prospect of industrialization in various fields and have become a research hotspot in areas of light-heat utilization, solar energy capture,...
5.
Jia Y, Yao Y, Fan L, Huang Q, Wei G, Shen P, et al.
J Nanobiotechnology
. 2024 Jun;
22(1):346.
PMID: 38898493
Chemoresistance remains a significant challenge for effective breast cancer treatment which leads to cancer recurrence. CRISPR-directed gene editing becomes a powerful tool to reduce chemoresistance by reprogramming the tumor microenvironment....
6.
Wei G, Zhu J, Hu H, Liu J
Gene
. 2020 Dec;
771:145365.
PMID: 33346098
Circular RNAs (circRNAs), a group of non-coding RNA characterized by the presence of covalent bonds linking 3' and 5' ends, act as miRNA sponges to participate in the tumorigenesis. Being...